Ausgabe 9/2013
Inhalt (35 Artikel)
Pancreatic safety of GLP-1-based therapeutic agents: further insights from rodent studies?
Jens Juul Holst
Who was first to diagnose and report neuropathic arthropathy of the foot and ankle: Jean-Martin Charcot or Herbert William Page?
Lee J. Sanders, Michael E. Edmonds, William J. Jeffcoate
Do current incretin mimetics exploit the full therapeutic potential inherent in GLP-1 receptor stimulation?
M. A. Nauck, O. Baranov, R. A. Ritzel, J. J. Meier
Setting the record straight on TIDE: a lost opportunity for patients with diabetes
Zubin Punthakee, Jackie Bosch, Hertzel C. Gerstein
Molecular mechanism of action of metformin: old or new insights?
Graham Rena, Ewan R. Pearson, Kei Sakamoto
The association of the mitochondrial DNA OriB variant (16184–16193 polycytosine tract) with type 2 diabetes in Europid populations
Zheng Ye, Christopher Gillson, Matt Sims, Kay-Tee Khaw, Magdalena Plotka, Joanna Poulton, Claudia Langenberg, Nicholas J. Wareham
Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial
Andrei Keidar, Karen J. Hershkop, Limor Marko, Chaya Schweiger, Lior Hecht, Noam Bartov, Assaf Kedar, Ram Weiss
The use of intermediate endpoints in the design of type 1 diabetes prevention trials
Jeffrey P. Krischer
UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82
A. J. Hayes, J. Leal, A. M. Gray, R. R. Holman, P. M. Clarke
Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy
S. Wheeler, K. Moore, C. W. Forsberg, K. Riley, J. S. Floyd, N. L. Smith, E. J. Boyko
Cancer detection rates following enrolment in a disease management programme for type 2 diabetes
A. S. Geier, J. Wellmann, I. Wellmann, H. Kajüter, O. Heidinger, G. Hempel, H. W. Hense
Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition
M. A. Schroijen, M. W. M. van de Luijtgaarden, M. Noordzij, P. Ravani, F. Jarraya, F. Collart, K. G. Prütz, D. G. Fogarty, T. Leivestad, F. C. Prischl, C. Wanner, F. W. Dekker, K. J. Jager, O. M. Dekkers
Improved genetic testing for monogenic diabetes using targeted next-generation sequencing
S. Ellard, H. Lango Allen, E. De Franco, S. E. Flanagan, G. Hysenaj, K. Colclough, J. A. L. Houghton, M. Shepherd, A. T. Hattersley, M. N. Weedon, R. Caswell
In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions
E. Mbunwe, B. J. Van der Auwera, I. Weets, P. Van Crombrugge, L. Crenier, M. Coeckelberghs, N. Seret, K. Decochez, E. Vandemeulebroucke, P. Gillard, B. Keymeulen, C. van Schravendijk, J. M. Wenzlau, J. C. Hutton, D. G. Pipeleers, F. K. Gorus
Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-α
A. Meerson, M. Traurig, V. Ossowski, J. M. Fleming, M. Mullins, L. J. Baier
Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice
J. H. Ellenbroek, H. A. M. Töns, M. J. A. Westerouen van Meeteren, N. de Graaf, M. A. Hanegraaf, T. J. Rabelink, F. Carlotti, E. J. P. de Koning
Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice
Jennifer E. Bruin, Alireza Rezania, Jean Xu, Kavitha Narayan, Jessica K. Fox, John J. O’Neil, Timothy J. Kieffer
Deficiency of APPL1 in mice impairs glucose-stimulated insulin secretion through inhibition of pancreatic beta cell mitochondrial function
Chen Wang, Xiaowen Li, Kaida Mu, Ling Li, Shihong Wang, Yunxia Zhu, Mingliang Zhang, Jiyoon Ryu, Zhifang Xie, Dongyun Shi, Weiping J. Zhang, Lily Q. Dong, Weiping Jia
The loss of Sirt1 in mouse pancreatic beta cells impairs insulin secretion by disrupting glucose sensing
L. Luu, F. F. Dai, K. J. Prentice, X. Huang, A. B. Hardy, J. B. Hansen, Y. Liu, J. W. Joseph, M. B. Wheeler
A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipid
S. Forbes, I. F. Godsland, S. D. Taylor-Robinson, J. D. Bell, E. L. Thomas, N. Patel, G. Hamilton, K. H. Parker, I. Marshall, C. D. Gray, D. Bedford, M. Caslake, B. R. Walker, D. G. Johnston
Acute reduction of lipolysis reduces adiponectin and IL-18: evidence from an intervention study with acipimox and insulin
B. Lindegaard, S. Ditlevsen, P. Plomgaard, B. Mittendorfer, B. K. Pedersen
LXR is a negative regulator of glucose uptake in human adipocytes
A. M. L. Pettersson, B. M. Stenson, S. Lorente-Cebrián, D. P. Andersson, N. Mejhert, J. Krätzel, G. Åström, I. Dahlman, A. V. Chibalin, P. Arner, J. Laurencikiene
Improvement in hepatic insulin sensitivity after Roux-en-Y gastric bypass in a rat model of obesity is partially mediated via hypothalamic insulin action
S. A. Paranjape, O. Chan, W. Zhu, N. K. Acharya, A. M. Rogers, A. Hajnal, R. S. Sherwin
Hepatic DNA methylation modifications in early development of rats resulting from perinatal BPA exposure contribute to insulin resistance in adulthood
Y. Ma, W. Xia, D. Q. Wang, Y. J. Wan, B. Xu, X. Chen, Y. Y. Li, S. Q. Xu
Caveolin-1 deficiency protects against mesangial matrix expansion in a mouse model of type 1 diabetic nephropathy
T. H. Guan, G. Chen, B. Gao, M. R. Janssen, L. Uttarwar, A. J. Ingram, J. C. Krepinsky
Fatty acids differentially regulate insulin resistance through endoplasm reticulum stress-mediated induction of tribbles homologue 3: a potential link between dietary fat composition and the pathophysiological outcomes of obesity
T. Geng, W. Hu, M. H. Broadwater, J. M. Snider, J. Bielawski, S. B. Russo, J. H. Schwacke, J. Ross, L. A. Cowart
Continuous hypothalamic KATP activation blunts glucose counter-regulation in vivo in rats and suppresses KATP conductance in vitro
Craig Beall, Elizabeth Haythorne, Xiaoning Fan, Qingyou Du, Sofija Jovanovic, Robert S. Sherwin, Michael L. J. Ashford, Rory J. McCrimmon
DNA methylation in monozygotic quadruplets affected by type 1 diabetes
Giulio Disanto, Jana Vcelakova, Julia Pakpoor, Ramyiadarsini I. Elangovan, Zdenek Sumnik, Tereza Ulmannova, George C. Ebers, Sreeram V. Ramagopalan, Kateřina Štechová
Secondary analysis of electronic databases: potentials and limitations
S. Asghari, M. Mahdavian
Secondary analysis of electronic databases: potentials and limitations. Reply to Asghari S, Mahdavian M [letter]
K. Kostev, W. Rathmann
The vitamin K-dependent Gla proteins and risk of type 2 diabetes
R. L. Kennedy, V. Vangaveti, U. H. Malabu, D. McCulloch
RETRACTED ARTICLE: Common variation in PPARGC1A/B and progression to diabetes or change in metabolic traits following preventive interventions: the Diabetes Prevention Program
P. W. Franks, C. A. Christophi, K. A. Jablonski, L. M. Delahanty, E. S. Horton, W. C. Knowler, J. C. Florez
Erratum to: Differences between amyloid toxicity in alpha and beta cells in human and mouse islets and the role of caspase-3
E. Law, S. Lu, T. J. Kieffer, G. L. Warnock, Z. Ao, M. Woo, L. Marzban
Erratum to: Intensive glucose control and risk of cancer in patients with type 2 diabetes
G. Stefansdottir, S. Zoungas, J. Chalmers, A. P. Kengne, M. J. Knol, H. G. M. Leufkens, A. Patel, M. Woodward, D. E. Grobbee, M. L. De Bruin